Depletion of intracellular GSH and NPSH by buthionine sulfoximine and diethyl maleate: factors that influence enhancement of aerobic radiation response
- PMID: 6469743
- DOI: 10.1016/0360-3016(84)90323-7
Depletion of intracellular GSH and NPSH by buthionine sulfoximine and diethyl maleate: factors that influence enhancement of aerobic radiation response
Abstract
Many investigators have observed aerobic sensitization of V79, CHO and A549 (human lung carcinoma) cells upon depletion of GSH using buthionine sulfoximine (BSO). Recently we discovered that this aerobic sensitization can be reversed if WR-2721 or N-acetylcysteine is added to the cells just prior to irradiation. Reversal requires that the exogenous thiols be present during the time of irradiation. One possible explanation was that these thiols entered the cells and either increased the pool of cellular nonprotein thiols or reversed the thiol-depleted state by stimulation of GSH synthesis. Cells treated with BSO do not readily regenerate intracellular GSH because this agent irreversibly inhibits gamma-glutamyl synthetase. For A549 monolayer cultures, there is approximately 50% regeneration 6 hr after removal of 0.01 mM BSO, 20% 6 hr after 0.1 mM BSO, and only 5% 6 hr after 0.5 mM BSO. We found that addition of WR-2721 or N-acetylcysteine to BSO-treated cells did not affect the rate of regeneration of intracellular GSH. Thus, reversal of the aerobic sensitization of A549 cells by BSO cannot be explained on the basis of intracellular thiol levels alone, or by rapid reversal of BSO inhibition. In addition, diethylmaleate (DEM)-treated cells are considerably different from BSO-treated cells with respect to the ability to regenerate GSH. After removal of DEM, A549 cells immediately begin GSH resynthesis, and return to control levels occurs within 2 hr. Exogenous 5 mM GSH increases the rate of resynthesis of GSH in DEM-treated cells, but not in BSO-treated cells.
Similar articles
-
Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.Radiat Res. 1983 Nov;96(2):422-8. Radiat Res. 1983. PMID: 6647769
-
Factors involved in depletion of glutathione from A549 human lung carcinoma cells: implications for radiotherapy.Int J Radiat Oncol Biol Phys. 1984 Aug;10(8):1221-7. doi: 10.1016/0360-3016(84)90322-5. Int J Radiat Oncol Biol Phys. 1984. PMID: 6469742
-
The role of thiols in cellular response to radiation and drugs.Radiat Res. 1983 Sep;95(3):437-55. Radiat Res. 1983. PMID: 6684310
-
In vivo and in vitro mechanisms of radiation sensitization, drug synthesis and screening: can we learn it all from the high dose data?Int J Radiat Oncol Biol Phys. 1984 Aug;10(8):1185-93. doi: 10.1016/0360-3016(84)90315-8. Int J Radiat Oncol Biol Phys. 1984. PMID: 6381430 Review.
-
Glutathione modulation in cancer treatment: will it work?Int J Radiat Oncol Biol Phys. 1989 May;16(5):1289-95. doi: 10.1016/0360-3016(89)90301-5. Int J Radiat Oncol Biol Phys. 1989. PMID: 2654105 Review.
Cited by
-
Induction of glutathione-dependent DNA double-strand breaks by the novel anticancer drug brostallicin.Mol Cancer Ther. 2009 Jul;8(7):1985-94. doi: 10.1158/1535-7163.MCT-09-0320. Epub 2009 Jul 7. Mol Cancer Ther. 2009. PMID: 19584235 Free PMC article.
-
Insights into Vincristine-Induced Peripheral Neuropathy in Aged Rats: Wallerian Degeneration, Oxidative Damage, and Alterations in ATPase Enzymes.ACS Chem Neurosci. 2024 Nov 6;15(21):3954-3969. doi: 10.1021/acschemneuro.4c00342. Epub 2024 Aug 29. ACS Chem Neurosci. 2024. PMID: 39207203 Free PMC article.
-
NRF2 Mediates Cellular Resistance to Transformation, Radiation, and Inflammation in Mice.Antioxidants (Basel). 2022 Aug 25;11(9):1649. doi: 10.3390/antiox11091649. Antioxidants (Basel). 2022. PMID: 36139722 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources